Skip to content

DrugPatentWatch - Transform Data into Market Domination

Blog Home
DrugPatentWatch Home
Plans & Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Blog Home
DrugPatentWatch Home
Plans & Pricing
About
Contact

Figure 1. Compounds linked to human protein targets

Leave a Comment / By DrugPatentWatch / November 26, 2017

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

Tracking 20 Years of Compound-to-Target Output from…
Artificial intelligence in drug discovery: what is…
List of NIH-Licensed Technologies
Contribution of NIH funding to new drug approvals 2010–2016
Bayer’s in silico ADMET platform: a journey of…
Exploring Drug Repositioning Approaches and Resources
Drug Repurposing: An Overview
Measuring the effectiveness and impact of an open…
A comprehensive review of database resources in chemistry
How AI Is Already Changing Drug Development
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Measuring the knowledge translation and convergence…
The Role of Artificial Intelligence (AI) and Machine…
Can Artificial Intelligence Help Drug Development?…
The Application of Machine Learning in Drug…
Patenting human genes: Chinese academic articles’…
Deep Learning in Drug Discovery and Medicine -…
Review of Drugs Approved via the 505(b)(2) Pathway:…
Pharmacognosy and Drug Patents: Unveiling Nature's…
Differences in rates of switchbacks after switching…
CDCDB: A large and continuously updated drug…
The Biosimilar Landscape: An Overview of Regulatory…
Ten years of biosimilars in Europe: development and…
How Artificial Intelligence Will Affect Healthcare…

Post navigation

Tracking 20 Years of Compound-to-Target Output from Literature and Patents

Get Email Updates

Email

Upcoming Drug Patent Expirations

Make Better Decisions

See Plans & Pricing

Recent Posts

Drafting Effective Drug Patent Applications: Turning Science into Market Power
Decoding Drug Pricing Models: A Strategic Guide to Market Domination
Patient-Centric Approaches to Maintaining Brand Value
AI-Based Drug Repurposing for Neurological Disorders: Current Status
Regulatory considerations for biosimilar extrapolation of indications

Popular Posts

The Role of China in the Global Generic Drug API Market
Drug Patent Life: The Complete Guide to Pharmaceutical Patent Duration and Market Exclusivity
Sourcing the Key Starting Materials (KSMs) for pharmaceutical Active Pharmaceutical Ingredients (APIs)
Handling Drug Patent Invalidity Claims
Valuation of Pharma Companies: 5 Key Considerations
Top 6 issues facing the biotechnology industry
Decoding Drug Pricing Models: A Strategic Guide to Market Domination
Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements
Patient-Centric Approaches to Maintaining Brand Value
Understanding Pharmaceutical Competitor Analysis

Copyright © 2025 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested